Terms: = Lymphoma AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Treatment
227 results:
1. Pre-treatment [
Chen J; Zhao Y
Hematology; 2024 Dec; 29(1):2325317. PubMed ID: 38465661
[TBL] [Abstract] [Full Text] [Related]
2. Childhood-onset systemic lupus erythematosus (cSLE) and malignancy: a nationwide multicentre series review.
Brufatto MZ; Lanças SHS; de Albuquerque Pedrosa Fernandes T; Sallum AME; Campos LMA; Sakamoto AP; Terreri MT; Sztajnbok FR; Bica BERG; Ferriani VPL; de Carvalho LM; Silva CAA; Saad-Magalhaes C
Adv Rheumatol; 2024 Feb; 64(1):13. PubMed ID: 38321580
[TBL] [Abstract] [Full Text] [Related]
3. Pharmacokinetics, metabolism, excretion and safety of iruplinalkib (WX-0593), a novel ALK inhibitor, in healthy subjects: a phase I human radiolabeled mass balance study.
Bian Y; Ma S; Yao Q; Hu T; Ge M; Li H; Zheng S; Gu Z; Feng H; Yu Z; Huang C; Zhang H; Zhao L; Miao L
Expert Opin Investig Drugs; 2024 Jan; 33(1):63-72. PubMed ID: 38224050
[TBL] [Abstract] [Full Text] [Related]
4. Utility of
Chen J; Li XL; Huang M
Clin Radiol; 2024 Mar; 79(3):205-212. PubMed ID: 38218705
[TBL] [Abstract] [Full Text] [Related]
5. MYCT1 inhibits hematopoiesis in diffuse large B-cell lymphoma by suppressing RUNX1 transcription.
Liang Y; Wei X; Yue PJ; Zhang HC; Li ZN; Wang XX; Sun YY; Fu WN
Cell Mol Biol Lett; 2024 Jan; 29(1):5. PubMed ID: 38172714
[TBL] [Abstract] [Full Text] [Related]
6. Deep learning for [
Häggström I; Leithner D; Alvén J; Campanella G; Abusamra M; Zhang H; Chhabra S; Beer L; Haug A; Salles G; Raderer M; Staber PB; Becker A; Hricak H; Fuchs TJ; Schöder H; Mayerhoefer ME
Lancet Digit Health; 2024 Feb; 6(2):e114-e125. PubMed ID: 38135556
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of manual and automated approaches for segmentation and extraction of quantitative indices from [
Krokos G; Kotwal T; Malaih A; Barrington S; Jackson P; Hicks RJ; Marsden PK; Fischer BM
Biomed Phys Eng Express; 2024 Jan; 10(2):. PubMed ID: 38100790
[TBL] [Abstract] [Full Text] [Related]
8. Differentiation of cancer of unknown primary and lymphoma in head and neck metastatic poorly differentiated cancer using 18 F-FDG PET/CT tumor metabolic heterogeneity index.
Xu M; Gu B; Zhang J; Xu X; Qiao Y; Hu S; Song S
Nucl Med Commun; 2024 Feb; 45(2):148-154. PubMed ID: 38095143
[TBL] [Abstract] [Full Text] [Related]
9. CXCR4-directed PET/CT with [
Dreher N; Hahner S; Fuß CT; Schlötelburg W; Hartrampf PE; Serfling SE; Schirbel A; Samnick S; Higuchi T; Weich A; Lapa C; Rosenwald A; Buck AK; Kircher S; Werner RA
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1383-1394. PubMed ID: 38082196
[TBL] [Abstract] [Full Text] [Related]
10. Micafungin twice-a-week for prophylaxis of invasive Aspergillus infections in children with acute lymphoblastic leukaemia: A controlled cohort study.
Bury D; Wolfs TFW; Muilwijk EW; Fiocco M; Pieters R; Brüggemann RJ; Tissing WJE
Int J Antimicrob Agents; 2024 Jan; 63(1):107058. PubMed ID: 38081549
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung Cancer.
Chen J; Bearz A; Kim DW; Mamdani H; Bauman J; Chiari R; Ou SI; Solomon BJ; Soo RA; Felip E; Shaw AT; Thurm H; Clancy JS; Lee K; O'Gorman M; Tanski C; Pithavala YK
Clin Pharmacokinet; 2024 Feb; 63(2):171-182. PubMed ID: 38079095
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic Value of Baseline Tumor Burden and Tumor Dissemination Extracted From 18 F-FDG PET/CT in a Cohort of Adult Patients With Early or Advanced Hodgkin lymphoma.
Mouheb M; Pierre-Jean M; Devillers A; Fermé C; Benchalal M; Manson G; Le Jeune F; Houot R; Palard-Novello X
Clin Nucl Med; 2024 Jan; 49(1):e1-e5. PubMed ID: 38015041
[TBL] [Abstract] [Full Text] [Related]
13. Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial.
Cottereau AS; Rebaud L; Trotman J; Feugier P; Nastoupil LJ; Bachy E; Flinn IW; Haioun C; Ysebaert L; Bartlett NL; Tilly H; Casasnovas O; Ricci R; Portugues C; Buvat I; Meignan M; Morschhauser F
Ann Oncol; 2024 Jan; 35(1):130-137. PubMed ID: 37898239
[TBL] [Abstract] [Full Text] [Related]
14. Impact of baseline and interim quantitative PET parameters on outcomes of classical Hodgkin lymphoma.
Santos FM; Marin JFG; Lima MS; Silva-Junior WF; Alves LBO; Moreira FR; Velasques RD; Atanazio MJ; Maia ACA; Buchpiguel CA; Buccheri V; Rocha V
Ann Hematol; 2024 Jan; 103(1):175-183. PubMed ID: 37796339
[TBL] [Abstract] [Full Text] [Related]
15. Effect of itraconazole and fluconazole on the pharmacokinetics of valemetostat: An open-label, phase I study in healthy subjects.
Tachibana M; Matsuki S; Maekawa Y; Kuroda K; Shimizu T; Tsutsumi J; Ishizuka H
Clin Transl Sci; 2023 Nov; 16(11):2153-2162. PubMed ID: 37705321
[TBL] [Abstract] [Full Text] [Related]
16. Safety, Tolerability, and Pharmacokinetics of Valemetostat Tablets and the Effect of Food on Valemetostat Pharmacokinetics in Healthy Subjects: Two Phase 1 Studies.
Tachibana M; Matsuki S; Toyama K; Maekawa Y; Fukae M; Shimizu T; Tsutsumi J; Shinohara S; Ishizuka H
Clin Pharmacol Drug Dev; 2024 Jan; 13(1):77-86. PubMed ID: 37565616
[TBL] [Abstract] [Full Text] [Related]
17. Effects of MYC Inhibitors on the Growth of Acute Leukaemia Cells.
Noguchi K; Itoh M; Ito C; Tohda S
Anticancer Res; 2023 Jul; 43(7):3023-3028. PubMed ID: 37351975
[TBL] [Abstract] [Full Text] [Related]
18. Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.
Chi SN; Yi JS; Williams PM; Roy-Chowdhuri S; Patton DR; Coffey BD; Reid JM; Piao J; Saguilig L; Alonzo TA; Berg SL; Ramirez NC; Jaju A; Mhlanga JC; Fox E; Hawkins DS; Mooney MM; Takebe N; Tricoli JV; Janeway KA; Seibel NL; Parsons DW
J Natl Cancer Inst; 2023 Nov; 115(11):1355-1363. PubMed ID: 37228094
[TBL] [Abstract] [Full Text] [Related]
19. Central nervous system thrombosis in pediatric acute lymphoblastic leukemia in Turkey: A multicenter study.
Guzelkucuk Z; Karapınar DY; Gelen SA; Tokgoz H; Ozcan A; Ay Y; Bahadır A; Ozbek NY; Oren AC; Ayhan AC; Akyay A; Akıncı B; Karadas N; Unuvar A; Oren H; Fettah A; Kaya Z; Isık B; Eker İ; Karaman S; Yıldırım AT; Orhan MF; Oymak Y; Timur C; Yazici N; Simsek A; Karakurt N; Toret E; Evim MS
Pediatr Blood Cancer; 2023 Aug; 70(8):e30425. PubMed ID: 37194482
[TBL] [Abstract] [Full Text] [Related]
20. Helical tomotherapy and two types of volumetric modulated arc therapy: dosimetric and clinical comparison for several cancer sites.
Gallio E; Sardo A; Badellino S; Mantovani C; Levis M; Fiandra C; Guarneri A; Arcadipane F; Richetto V; Ricardi U; Giglioli FR
Radiol Phys Technol; 2023 Jun; 16(2):272-283. PubMed ID: 37084071
[TBL] [Abstract] [Full Text] [Related]
[Next]
